Zhuoying He

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy

Youmei Xiao, Zhuoying He, Wanqiong Li et al. · Nature Communications · 2025 · 72 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma

Xinghua Sui, Chunxia Chen, Xiuman Zhou et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +17

Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy

Xin Yang, Wanqiong Li, Shuzhen Li et al. · Journal of Controlled Release · 2023 · 35 citations

Pharmacy, Oncology, Pharmacology +14

Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy

Zheng Hu, Wanqiong Li, Shaomeng Chen et al. · Science China Life Sciences · 2023 · 32 citations

Life Sciences, Immunology, Oncology +16